Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
about
Mechanisms underlying the exquisite sensitivity of Candida albicans to combinatorial cationic and oxidative stress that enhances the potent fungicidal activity of phagocytes.Canadian clinical practice guidelines for invasive candidiasis in adults.Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.Antifungal treatment strategies in patients with haematological diseases or cancer: from prophylaxis to empirical, pre-emptive and targeted therapy.Antifungal prophylaxis with micafungin in neutropenic patients with hematological malignancies.In meta-analysis itraconazole is superior to fluconazole for prophylaxis of systemic fungal infection in the treatment of haematological malignancy.
P2860
Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Evidence-based review of antif ...... h haematological malignancies.
@ast
Evidence-based review of antif ...... h haematological malignancies.
@en
type
label
Evidence-based review of antif ...... h haematological malignancies.
@ast
Evidence-based review of antif ...... h haematological malignancies.
@en
prefLabel
Evidence-based review of antif ...... h haematological malignancies.
@ast
Evidence-based review of antif ...... h haematological malignancies.
@en
P356
P1476
Evidence-based review of antif ...... h haematological malignancies.
@en
P2093
Archibald Grant Prentice
Axel Glasmacher
P304
P356
10.1093/JAC/DKI221
P407
P478
56 Suppl 1
P577
2005-09-01T00:00:00Z